Eligibility for the Index of Legally Marketed Unapproved New Animal Drugs for Minor Species; Request for Comments

Summary

The US Food and Drug Administration (FDA) is seeking public input on its policy for adding unapproved animal drugs to its Index of Legally Marketed Unapproved New Animal Drugs for Minor Species. The FDA is considering changes to its current policy, which restricts eligibility for indexing to certain animal species.